SG131765A1 - New [3,4-a:3,4-c]carbazole compounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents
New [3,4-a:3,4-c]carbazole compounds, a process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- SG131765A1 SG131765A1 SG200306491-2A SG2003064912A SG131765A1 SG 131765 A1 SG131765 A1 SG 131765A1 SG 2003064912 A SG2003064912 A SG 2003064912A SG 131765 A1 SG131765 A1 SG 131765A1
- Authority
- SG
- Singapore
- Prior art keywords
- preparation
- new
- pharmaceutical compositions
- compositions containing
- carbazole compounds
- Prior art date
Links
- 125000000609 carbazolyl group Chemical class C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0212847A FR2845996A1 (fr) | 2002-10-16 | 2002-10-16 | Nouveaux derives de[3,4-a:3,4-c]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG131765A1 true SG131765A1 (en) | 2007-05-28 |
Family
ID=29725330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200306491-2A SG131765A1 (en) | 2002-10-16 | 2003-10-16 | New [3,4-a:3,4-c]carbazole compounds, a process for their preparation and pharmaceutical compositions containing them |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7151108B2 (de) |
| EP (1) | EP1411057B1 (de) |
| JP (1) | JP2004277404A (de) |
| KR (1) | KR100502250B1 (de) |
| CN (1) | CN1241925C (de) |
| AR (1) | AR041618A1 (de) |
| AT (1) | ATE294181T1 (de) |
| AU (1) | AU2003254746A1 (de) |
| BR (1) | BR0304575A (de) |
| CA (1) | CA2443585A1 (de) |
| DE (1) | DE60300571T2 (de) |
| DK (1) | DK1411057T3 (de) |
| EA (1) | EA007250B1 (de) |
| ES (1) | ES2240927T3 (de) |
| FR (1) | FR2845996A1 (de) |
| MA (1) | MA27007A1 (de) |
| MX (1) | MXPA03009362A (de) |
| MY (1) | MY134620A (de) |
| NO (1) | NO20034614L (de) |
| NZ (1) | NZ528902A (de) |
| PL (1) | PL362885A1 (de) |
| PT (1) | PT1411057E (de) |
| SG (1) | SG131765A1 (de) |
| SI (1) | SI1411057T1 (de) |
| ZA (1) | ZA200308053B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI499414B (zh) | 2006-09-29 | 2015-09-11 | Lexicon Pharmaceuticals Inc | 鈉與葡萄糖第2型共同運輸體(co-transporter 2)的抑制物與其應用方法 |
| WO2008109591A1 (en) | 2007-03-08 | 2008-09-12 | Lexicon Pharmaceuticals, Inc. | Phlorizin analogs as inhibitors of sodium glucose co-transporter 2 |
| CA2939164A1 (en) | 2014-02-12 | 2015-08-20 | Iteos Therapeutics | Novel 3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use |
| CN103804278B (zh) * | 2014-02-19 | 2016-04-13 | 西北大学 | 一种天然产物2-甲基-3-甲氧基-咔唑-1,4-苯醌的制备方法 |
| PE20170247A1 (es) | 2014-05-15 | 2017-03-29 | Iteos Therapeutics | Derivados de pirrolidina-2,5-diona, composiciones farmaceuticas y metodos para usar como inhibidores ido1 |
| WO2016147144A1 (en) | 2015-03-17 | 2016-09-22 | Pfizer Inc. | Novel 3-indol substituted derivatives, pharmaceutical compositions and methods for use |
| JP2016216446A (ja) * | 2015-05-14 | 2016-12-22 | ファイザー・インク | ピロリジン−2,5−ジオン誘導体の多形形態、医薬組成物、およびido1阻害薬としての使用方法 |
| EP3334733A1 (de) | 2015-08-10 | 2018-06-20 | Pfizer Inc | 3-indol-substituierte derivate, pharmazeutische zusammensetzungen und verfahren zur verwendung |
| CN106832175B (zh) * | 2017-02-17 | 2019-10-18 | 华南理工大学 | 一种基于咔唑衍生物的双羟基荧光扩链剂及其制备与应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3010675B2 (ja) * | 1989-03-23 | 2000-02-21 | 萬有製薬株式会社 | 抗腫瘍性物質be―13793c |
-
2002
- 2002-10-16 FR FR0212847A patent/FR2845996A1/fr not_active Withdrawn
-
2003
- 2003-09-19 MY MYPI20033597A patent/MY134620A/en unknown
- 2003-09-26 US US10/672,418 patent/US7151108B2/en not_active Expired - Fee Related
- 2003-09-26 MA MA27327A patent/MA27007A1/fr unknown
- 2003-10-13 MX MXPA03009362A patent/MXPA03009362A/es active IP Right Grant
- 2003-10-14 ES ES03292545T patent/ES2240927T3/es not_active Expired - Lifetime
- 2003-10-14 DK DK03292545T patent/DK1411057T3/da active
- 2003-10-14 SI SI200330032T patent/SI1411057T1/xx unknown
- 2003-10-14 DE DE60300571T patent/DE60300571T2/de not_active Expired - Fee Related
- 2003-10-14 PT PT03292545T patent/PT1411057E/pt unknown
- 2003-10-14 AT AT03292545T patent/ATE294181T1/de not_active IP Right Cessation
- 2003-10-14 EP EP03292545A patent/EP1411057B1/de not_active Expired - Lifetime
- 2003-10-15 PL PL03362885A patent/PL362885A1/xx not_active Application Discontinuation
- 2003-10-15 KR KR10-2003-0071768A patent/KR100502250B1/ko not_active Expired - Fee Related
- 2003-10-15 NO NO20034614A patent/NO20034614L/no not_active Application Discontinuation
- 2003-10-15 NZ NZ528902A patent/NZ528902A/en unknown
- 2003-10-15 CA CA002443585A patent/CA2443585A1/fr not_active Abandoned
- 2003-10-15 AR ARP030103744A patent/AR041618A1/es unknown
- 2003-10-15 BR BR0304575-7A patent/BR0304575A/pt not_active IP Right Cessation
- 2003-10-15 EA EA200301020A patent/EA007250B1/ru unknown
- 2003-10-16 CN CNB200310100563XA patent/CN1241925C/zh not_active Expired - Fee Related
- 2003-10-16 JP JP2003355815A patent/JP2004277404A/ja active Pending
- 2003-10-16 SG SG200306491-2A patent/SG131765A1/en unknown
- 2003-10-16 ZA ZA200308053A patent/ZA200308053B/xx unknown
- 2003-10-16 AU AU2003254746A patent/AU2003254746A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1411057A1 (de) | 2004-04-21 |
| PT1411057E (pt) | 2005-08-31 |
| BR0304575A (pt) | 2004-07-20 |
| MY134620A (en) | 2007-12-31 |
| EA200301020A1 (ru) | 2004-04-29 |
| US7151108B2 (en) | 2006-12-19 |
| ATE294181T1 (de) | 2005-05-15 |
| US20040077672A1 (en) | 2004-04-22 |
| JP2004277404A (ja) | 2004-10-07 |
| DK1411057T3 (da) | 2005-08-29 |
| AU2003254746A1 (en) | 2004-05-06 |
| NZ528902A (en) | 2004-09-24 |
| NO20034614D0 (no) | 2003-10-15 |
| MA27007A1 (fr) | 2004-12-20 |
| EP1411057B1 (de) | 2005-04-27 |
| DE60300571D1 (de) | 2005-06-02 |
| KR20040034472A (ko) | 2004-04-28 |
| ES2240927T3 (es) | 2005-10-16 |
| NO20034614L (no) | 2004-04-19 |
| ZA200308053B (en) | 2004-07-08 |
| CA2443585A1 (fr) | 2004-04-16 |
| HK1063321A1 (en) | 2004-12-24 |
| MXPA03009362A (es) | 2004-04-28 |
| SI1411057T1 (de) | 2005-08-31 |
| DE60300571T2 (de) | 2006-02-23 |
| PL362885A1 (en) | 2004-04-19 |
| KR100502250B1 (ko) | 2005-07-20 |
| CN1241925C (zh) | 2006-02-15 |
| CN1496989A (zh) | 2004-05-19 |
| AR041618A1 (es) | 2005-05-26 |
| FR2845996A1 (fr) | 2004-04-23 |
| EA007250B1 (ru) | 2006-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0002843A3 (en) | New betha-carboline compounds, a process for their preparation and pharmaceutical compositions containing them | |
| AU2003239302A1 (en) | Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them | |
| HUP0203136A3 (en) | Piperazine compounds, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0301187A3 (en) | Novel benzyl-piperidine-derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0400208A3 (en) | N-formyl hydroxylamine compounds, process for their preparation and pharmaceutical compositions containing them | |
| HU0100489D0 (en) | New piperidine-4-sulphonamide compounds, process for their preparation and pharmaceutical compositions containing them | |
| PL359373A1 (en) | New substituted phthalides, a process for their preparation and pharmaceutical compositions containing them | |
| HUP0203976A3 (en) | Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them | |
| HUP0104272A3 (en) | New cyclobutendione compounds, a process for their preparation and pharmaceutical compositions containing them | |
| SG131765A1 (en) | New [3,4-a:3,4-c]carbazole compounds, a process for their preparation and pharmaceutical compositions containing them | |
| AU2003231920A8 (en) | Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them | |
| SG109010A1 (en) | New heterocyclic oxime compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HUP0301254A3 (en) | Novel compounds, process fo their preparation and pharmaceutical compositions containing them | |
| HUP0401082A3 (en) | Substituted 4-aminocyclohexanols, process for their preparation and pharmaceutical compositions containing them | |
| HUP0202379A3 (en) | New compounds, process for producing them and pharmaceutical compositions containing them | |
| IL147069A0 (en) | Novel benzene derivatives, a process for their preparation and pharmaceutical compositions containing them | |
| HU0105328D0 (en) | Novel bicyclic amino-pirazinone compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HUP0004573A3 (en) | New camptothecin analogue compounds, a process for their preparation and pharmaceutical compositions containing them | |
| ZA200202030B (en) | Isoindoloindolone compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| EG24369A (en) | New isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HUP0201024A3 (en) | Izoindeindolone compounds, process for their preparation and pharmaceutical compositions containing them | |
| AU2002300093A1 (en) | New benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HU9803017D0 (en) | New heterocyclic compounds, a process for their preparation and pharmaceutical compositions containing them | |
| SG110170A1 (en) | New benzoindoline compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HUP0004543A3 (en) | Aminopyrroline compounds, process for their preparation and pharmaceutical compositions containing them |